Brief: Evotec Receives $2.5 Mln Grant For Tb Treatments
07/05/2025 06:34
May 7 (Reuters) - EVOTEC SE EVTG.DE: EVOTEC SE - RECEIVES $2.5 MILLION GRANT FOR TB TREATMENTS EVOTEC SE - PARTNERSHIP AIMS TO REDUCE TB TREATMENT DURATION Source text: ID:nEQ8CRS7ja Further company coverage: EVTG.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases